Empirico
Eric Buss is a Senior Scientist at Empirico Inc. with experience in developing and implementing preclinical drug discovery programs for monogenetic CNS diseases. Prior to this role, Eric worked as a Scientist II at Exicure, where Eric focused on nucleic acid technologies. Eric also served as a Postdoctoral Research Scientist at Columbia University and holds a PhD in Neuroscience from RUSH University. Their academic background includes a Bachelor of Science in Behavioral Neuroscience from the University of Iowa.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.